Skip to main content
TipRanks
Go Ultimate75% OFF

PILA PHARMA AB (5KC) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

PILA PHARMA AB has a market cap or net worth of EUR 6.87M. The enterprise value is EUR 42.98M.

Market Cap
EUR 6.87M
Enterprise Value
EUR 42.98M

Share Statistics

PILA PHARMA AB has 45,682,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
45,682,120
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

PILA PHARMA AB’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -53.40%.

Return on Equity (ROE)
-1.14
Return on Assets (ROA)
-1.04
Return on Invested Capital (ROIC)
-53.40%
Return on Capital Employed (ROCE)
-0.53
Revenue Per Employee
1.13M
Profits Per Employee
-16.86M
Employee Count
1
Asset Turnover
0.07
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of PILA PHARMA AB is -4.12. PILA PHARMA AB’s PEG ratio is 4.77.

PE Ratio
-4.12
PS Ratio
277.50
PB Ratio
3.78
Price to FCF
-3.68
Price to Operating Cash Flow
-2.93
PEG Ratio
4.77

Income Statement

In the last 12 months, PILA PHARMA AB had revenue of 1.13M and earned -16.86M in profits. Earnings per share was -0.49.

Revenue
1.13M
Gross Profit
-6.82M
Operating Income
-7.89M
Pretax Income
-16.86M
Net Income
-16.86M
EBITDA
-15.92M
Earnings Per Share (EPS)
-0.49

Cash Flow

In the last 12 months, operating cash flow was -20.79M and capital expenditures 0, giving a free cash flow of -20.79M billion.

Operating Cash Flow
-20.79M
Free Cash Flow
-20.79M
Free Cash Flow per Share
-0.57

Dividends & Yields

PILA PHARMA AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-27.18%
Earnings Yield
-27.50%

Stock Price Statistics

Beta
0.18
52-Week Price Change
-22.28%
50-Day Moving Average
0.14
200-Day Moving Average
0.13
Relative Strength Index (RSI)
53.94
Average Volume (3m)
―

Important Dates

PILA PHARMA AB upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

PILA PHARMA AB as a current ratio of 11.26, with Debt / Equity ratio of 0.00%

Current Ratio
11.26
Quick Ratio
11.26
Debt to Market Cap
0.00
Net Debt to EBITDA
1.00
Interest Coverage Ratio
-36.05

Taxes

In the past 12 months, PILA PHARMA AB has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

PILA PHARMA AB EV to EBITDA ratio is -10.91, with an EV/FCF ratio of -3.52.

EV to Sales
265.69
EV to EBITDA
-10.91
EV to Free Cash Flow
-3.52
EV to Operating Cash Flow
-3.52

Balance Sheet

PILA PHARMA AB has EUR 3.26M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 3.26M billion.

Cash & Marketable Securities
EUR 3.26M
Total Debt
EUR 0.00
Net Cash
EUR 3.26M
Net Cash Per Share
EUR 0.07
Tangible Book Value Per Share
EUR 0.44

Margins

Gross margin is -2158.59%, with operating margin of -2825.74%, and net profit margin of -6080.90%.

Gross Margin
-2158.59%
Operating Margin
-2825.74%
Pretax Margin
-6080.90%
Net Profit Margin
-6080.90%
EBITDA Margin
-2435.09%
EBIT Margin
-2825.74%

Analyst Forecast

The average price target for PILA PHARMA AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-70.92%
EPS Growth Forecast
-27.35%